Proteina Co., Ltd.

Research Proteina Co., Ltd. (468530.KQ) on Bullrun: market cap KRW 413.51B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 413.51B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 413.51Bn/an/an/a

Dividend history

About Proteina Co., Ltd.

Proteina Co., Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is Proteina Co., Ltd.'s market cap?

Proteina Co., Ltd.'s market capitalization is KRW 413.51B.

What does Proteina Co., Ltd. do?

Proteina Co., Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.